DrugPatentWatch Database Preview
Sincalide - Generic Drug Details
What are the generic sources for sincalide and what is the scope of sincalide freedom to operate?
Sincalide has ten patent family members in eight countries.
There are two drug master file entries for sincalide. One supplier is listed for this compound.
Summary for sincalide
International Patents: | 10 |
US Patents: | 1 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 2 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 22 |
Clinical Trials: | 3 |
Patent Applications: | 477 |
Drug Prices: | see low prices |
DailyMed Link: | sincalide at DailyMed |
Pharmacology for sincalide
Ingredient-type | Cholecystokinin |
Drug Class | Cholecystokinin Analog |
Synonyms for sincalide
(3S,6S,9S,15S,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6,15-bis(2-(methylthio)ethyl)-5,8,11,14,17,20-hexaoxo-18-(4-(sulfooxy)benzyl)-4,7,10,13,16,19-hexaazatricosane-1,2 |
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S |
(3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-3-(4-sulfooxyphenyl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl |
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-(methylthio)-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino] |
(3S)-3-azanyl-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-4-oxidanyl-1,4-bis(oxidanylidene)butan-2-yl]amino]-4-methylsulfanyl-1-oxidanylidene-butan-2-yl]amino |
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide |
[125I]CCK-8 |
1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein |
126S323 |
25126-32-3 |
25345-10-2 |
89911-55-7 |
9038-72-6 |
91921-74-3 |
A817659 |
AKOS016340423 |
BDBM21147 |
C49H62N10O16S3 |
Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine- |
CAS-25126-32-3 |
CCK C-terminal octapeptide |
CCK Octapeptide, sulfated |
CCK-8 |
CCK-8 (sulphated) |
CCK-8(SO3) |
CHEBI:135946 |
CHEMBL1121 |
cholecystokinin 8 |
cholecystokinin C-terminal octapeptide |
cholecystokinin fragment 26-33 amide (sulphated) |
Cholecystokinin octapeptide |
Cholecystokinin Octapeptide, sulfated |
Cholecystokinin-8 |
Cholecystokinin-pancreozymin |
CS-5963 |
D05845 |
D0I8AF |
DB09142 |
DSSTox_CID_28543 |
DSSTox_GSID_48617 |
DSSTox_RID_82815 |
DTXSID7048617 |
EINECS 246-639-0 |
FT-0630515 |
GTPL864 |
H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 |
Human CCK-8 |
HY-P0093 |
IZTQOLKUZKXIRV-YRVFCXMDSA-N |
Kinevac |
Kinevac (TN) |
L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide |
L-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester) |
M03GIQ7Z6P |
MFCD00079849 |
MolPort-006-124-517 |
NCGC00167273-01 |
NCGC00183278-01 |
NCGC00183363-01 |
O411 |
Pancreozymin |
Pancreozymin C-terminal octapeptide |
SC-47569 |
SCHEMBL122365 |
Sincalida |
Sincalida [INN-Spanish] |
Sincalide (Kinevac) |
Sincalide (USP/INN) |
Sincalide [USAN:USP:INN:BAN] |
Sincalidum |
Sincalidum [INN-Latin] |
SQ 19844 |
SQ-19844 |
Syncalide |
Tox21_112955 |
Tox21_113481 |
UNII-M03GIQ7Z6P |
US Patents and Regulatory Information for sincalide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for sincalide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for sincalide
Country | Document Number | Estimated Expiration |
---|---|---|
Germany | 60336509 | ➤ Try a Free Trial |
Austria | 502647 | ➤ Try a Free Trial |
China | 1756557 | ➤ Try a Free Trial |
European Patent Office | 1631305 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:









Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.